Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
874.84
450.71
331.41
270.83
157.17
17.81
48.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
874.84
450.71
331.41
270.83
157.17
17.81
48.84
Raw Material Cost
20.46
13.73
6.32
8.03
8.04
1.68
4.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
78.87
98.52
108.24
99.09
59.29
14.50
11.89
Selling and Distribution Expenses
348.65
266.13
213.89
159.37
118.82
62.90
37.12
Other Expenses
8.59
7.49
10.67
15.28
14.87
10.85
9.52
Total Expenditure (Excl Depreciation)
533.85
453.25
435.12
419.26
334.89
187.54
148.29
Operating Profit (PBDIT) excl Other Income
341
-2.5
-103.69999999999999
-148.4
-177.7
-169.7
-99.5
Other Income
22.61
14.11
14.74
5.13
0.06
1.19
2.80
Operating Profit (PBDIT)
364.98
12.81
-87.32
-141.87
-176.88
-167.79
-95.93
Interest
78.87
98.52
108.24
99.09
59.29
14.50
11.89
Exceptional Items
-17.33
0.00
-29.02
-1.98
55.14
0.23
-0.35
Gross Profit (PBDT)
854.37
436.98
325.10
262.80
149.13
16.14
44.73
Depreciation
1.39
1.25
1.66
1.44
0.78
0.75
0.72
Profit Before Tax
267.39
-86.95
-226.23
-244.38
-181.81
-182.81
-108.90
Tax
3.53
1.93
0.31
2.73
2.25
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
263.86
-88.88
-226.54
-247.12
-184.06
-182.81
-108.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
263.86
-88.88
-226.54
-247.12
-184.06
-182.81
-108.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
263.86
-88.88
-226.54
-247.12
-184.06
-182.81
-108.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
-119.15
-475.93
-455.53
-294.60
-106.99
-19.26
38.25
Earnings per share (EPS)
1.21
-0.43
-1.18
-1.33
-1.03
-1.09
-0.94
Diluted Earnings per share
1.21
-0.43
-1.18
-1.33
-1.03
-1.09
-0.94
Operating Profit Margin (Excl OI)
38.98%
-0.56%
-31.29%
-54.81%
-113.08%
-952.9%
-203.66%
Gross Profit Margin
30.72%
-19.02%
-67.76%
-89.71%
-115.18%
-1022.15%
-221.51%
PAT Margin
30.16%
-19.72%
-68.36%
-91.24%
-117.11%
-1026.35%
-222.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 94.10% vs 36.00% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 396.85% vs 60.75% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 26,438.46% vs 98.73% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -19.90% vs -8.96% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of BioCryst Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
874.84
247.00
627.84
254.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
874.84
247.00
627.84
254.19%
Raw Material Cost
20.46
10.00
10.46
104.60%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
78.87
8.00
70.87
885.88%
Selling and Distribution Expenses
348.65
100.00
248.65
248.65%
Other Expenses
8.59
51.50
-42.91
-83.32%
Total Expenditure (Excl Depreciation)
533.85
633.00
-99.15
-15.66%
Operating Profit (PBDIT) excl Other Income
340.99
-386.00
726.99
188.34%
Other Income
22.61
41.00
-18.39
-44.85%
Operating Profit (PBDIT)
364.98
-335.00
699.98
208.95%
Interest
78.87
8.00
70.87
885.88%
Exceptional Items
-17.33
0.00
-17.33
Gross Profit (PBDT)
854.37
237.00
617.37
260.49%
Depreciation
1.39
10.00
-8.61
-86.10%
Profit Before Tax
267.39
-353.00
620.39
175.75%
Tax
3.53
0.00
3.53
Provisions and contingencies
0
0
0.00
Profit After Tax
263.86
-353.00
616.86
174.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
263.86
-353.00
616.86
174.75%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
263.86
-353.00
616.86
174.75%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
-119.15
631.00
-750.15
-118.88%
Earnings per share (EPS)
1.21
-3.29
4.50
136.78%
Diluted Earnings per share
1.21
-3.29
4.50
136.78%
Operating Profit Margin (Excl OI)
38.98%
-156.28%
0.00
195.26%
Gross Profit Margin
30.72%
-138.87%
0.00
169.59%
PAT Margin
30.16%
-142.91%
0.00
173.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 87.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 94.10% vs 36.00% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 26.39 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 396.85% vs 60.75% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.24 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 26,438.46% vs 98.73% in Dec 2024
Annual - Interest
Interest 7.89 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -19.90% vs -8.96% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.98%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
